|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 36:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cuzick J, DeCensi A, Arun B, Brown PH,
Castiglione M, Dunn B, Forbes JF, Glaus A, Howell A, von Minckwitz
G, et al: Preventive therapy for breast cancer: A consensus
statement. Lancet Oncol. 12:496–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Quintavalle M, Elia L, Condorelli G and
Courtneidge SA: MicroRNA control of podosome formation in vascular
smooth muscle cells in vivo and in vitro. J Cell Biol. 189:13–22.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dang X, Ma A, Yang L, Hu H, Zhu B, Shang
D, Chen T and Luo Y: MicroRNA-26a regulates tumorigenic properties
of EZH2 in human lung carcinoma cells. Cancer Genet. 205:113–123.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Inui M, Martello G and Piccolo S: MicroRNA
control of signal transduction. Nat Rev Mol Cell Biol. 11:252–263.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cordes KR, Sheehy NT, White MP, Berry EC,
Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN and Srivastava D:
miR-145 and miR-143 regulate smooth muscle cell fate and
plasticity. Nature. 460:705–710. 2009.PubMed/NCBI
|
|
8
|
Xu X, Chen Z, Zhao X, Wang J, Ding D, Wang
Z, Tan F, Tan X, Zhou F, Sun J, et al: MicroRNA-25 promotes cell
migration and invasion in esophageal squamous cell carcinoma.
Biochem Biophys Res Commun. 421:640–645. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Blenkiron C, Goldstein LD, Thorne NP,
Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE,
Green AR, Ellis IO, et al: MicroRNA expression profiling of human
breast cancer identifies new markers of tumor subtype. Genome Biol.
8:R2142007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lowery AJ, Miller N, Devaney A, McNeill
RE, Davoren PA, Lemetre C, Benes V, Schmidt S, Blake J, Ball G, et
al: MicroRNA signatures predict oestrogen receptor, progesterone
receptor and HER2/neu receptor status in breast cancer. Breast
Cancer Res. 11:R272009. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Foekens JA, Sieuwerts AM, Smid M, Look MP,
de Weerd V, Boersma AW, Klijn JG, Wiemer EA and Martens JW: Four
miRNAs associated with aggressiveness of lymph node-negative,
estrogen receptor-positive human breast cancer. Proc Natl Acad Sci
USA. 105:13021–13026. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rothé F, Ignatiadis M, Chaboteaux C,
Haibe-Kains B, Kheddoumi N, Majjaj S, Badran B, Fayyad-Kazan H,
Desmedt C, Harris AL, et al: Global microRNA expression profiling
identifies MiR-210 associated with tumor proliferation, invasion
and poor clinical outcome in breast cancer. PLoS One. 6:e209802011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bay A, Coskun E, Oztuzcu S, Ergun S,
Yilmaz F and Aktekin E: Plasma microRNA profiling of pediatric
patients with immune thrombocytopenic purpura. Blood Coagul
Fibrinolysis. 25:379–383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tulchinsky E: Fos family members:
Regulation, structure and role in oncogenic transformation. Histol
Histopathol. 15:921–928. 2000.PubMed/NCBI
|
|
15
|
Bozec A, Bakiri L, Jimenez M, Rosen ED,
Catalá-Lehnen P, Schinke T, Schett G, Amling M and Wagner EF:
Osteoblast-specific expression of Fra-2/AP-1 controls adiponectin
and osteocalcin expression and affects metabolism. J Cell Sci.
126:5432–5440. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Engel L, Gupta BB, Lorenzkowski V,
Heinrich B, Schwerdtle I, Gerhold S, Holthues H, Vollrath L and
Spessert R: Fos-related antigen 2 (Fra-2) memorizes photoperiod in
the rat pineal gland. Neuroscience. 132:511–518. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roy S, Khanna S, Azad A, Schnitt R, He G,
Weigert C, Ichijo H and Sen CK: Fra-2 mediates oxygen-sensitive
induction of transforming growth factor beta in cardiac
fibroblasts. Cardiovasc Res. 87:647–655. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou L, Graves M, MacDonald G, Cipollone
J, Mueller CR and Roskelley CD: Microenvironmental regulation of
BRCA1 gene expression by c-Jun and Fra2 in premalignant human
ovarian surface epithelial cells. Mol Cancer Res. 11:272–281. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ciofani M, Madar A, Galan C, Sellars M,
Mace K, Pauli F, Agarwal A, Huang W, Parkhurst CN, Muratet M, et
al: A validated regulatory network for Th17 cell specification.
Cell. 151:289–303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schröder C, Schumacher U, Müller V, Wirtz
RM, Streichert T, Richter U, Wicklein D and Milde-Langosch K: The
transcription factor Fra-2 promotes mammary tumour progression by
changing the adhesive properties of breast cancer cells. Eur J
Cancer. 46:1650–1660. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Milde-Langosch K, Röder H, Andritzky B,
Aslan B, Hemminger G, Brinkmann A, Bamberger CM, Löning T and
Bamberger AM: The role of the AP-1 transcription factors c-Fos,
FosB, Fra-1 and Fra-2 in the invasion process of mammary
carcinomas. Breast Cancer Res Treat. 86:139–152. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of micro- RNA genes miR15
and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad
Sci USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shaulian E and Karin M: AP-1 as a
regulator of cell life and death. Nat Cell Biol. 4:E131–E136. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eferl R and Wagner EF: AP-1: A
double-edged sword in tumorigenesis. Nat Rev Cancer. 3:859–868.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Daury L, Busson M, Tourkine N, Casas F,
Cassar-Malek I, Wrutniak-Cabello C, Castellazzi M and Cabello G:
Opposing functions of ATF2 and Fos-like transcription factors in
c-Jun-mediated myogenin expression and terminal differentiation of
avian myoblasts. Oncogene. 20:7998–8008. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Matsui M, Tokuhara M, Konuma Y, Nomura N
and Ishizaki R: Isolation of human fos-related genes and their
expression during monocyte-macrophage differentiation. Oncogene.
5:249–255. 1990.PubMed/NCBI
|
|
27
|
Nishina H, Sato H, Suzuki T, Sato M and
Iba H: Isolation and characterization of fra-2, an additional
member of the fos gene family. Proc Natl Acad Sci USA.
87:3619–3623. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Z, Zhan W, Wang Z, Zhu B, He Y, Peng J,
Cai S and Ma J: Inhibition of PRL-3 gene expression in gastric
cancer cell line SGC7901 via microRNA suppressed reduces peritoneal
metastasis. Biochem Biophys Res Commun. 348:229–237. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Y, Han Y, Zhang H, Nie L, Jiang Z, Fa
P, Gui Y and Cai Z: Synthetic miRNA-mowers targeting miR-183-96-182
cluster or miR-210 inhibit growth and migration and induce
apoptosis in bladder cancer cells. PLoS One. 7:e522802012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu X, Fang H, Chen H, Jiang X, Fang D,
Wang Y and Zhu D: An artificial miRNA against HPSE suppresses
melanoma invasion properties, correlating with a down-regulation of
chemokines and MAPK phosphorylation. PLoS One. 7:e386592012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liang Z, Wu H, Reddy S, Zhu A, Wang S,
Blevins D, Yoon Y, Zhang Y and Shim H: Blockade of invasion and
metastasis of breast cancer cells via targeting CXCR4 with an
artificial microRNA. Biochem Biophys Res Commun. 363:542–546. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang S, Shu JZ, Cai Y, Bao Z and Liang QM:
Establishment and characterization of MTDH knockdown by artificial
MicroRNA interference - functions as a potential tumor suppressor
in breast cancer. Asian Pac J Cancer Prev. 13:2813–2818. 2012.
View Article : Google Scholar : PubMed/NCBI
|
